Skip to Main Content

Paper Details

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
J Pathol
6
2023
Breast Cancer, HER2, HER2-positive breast cancer, TIL, TILs, breast cancer, estrogen, estrogen receptor, patients, progesterone, progesterone receptor, triple-negative (estrogen receptor, progesterone receptor, and HER2-negative) breast cancer, triple-negative breast cancer, tumor-infiltrating lymphocytes, validation issues
Author NameAffiliation
Jonas S AlmeidaNational Cancer Institute (NCI)
Lee A D CooperNorthwestern Feinberg School of Medicine
Lee A D CooperNorthwestern Feinberg School of Medicine
Anders Bjorholm DahlTechnical University of Denmark
Sandra Demaria
Sandra Demaria
William M GallagherUCD Conway Institute, University College Dublin
Sacha GnjaticTisch Cancer Institute - Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticTisch Cancer Institute - Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Paula I Gonzalez-EricssonVanderbilt University Medical Center
Stephen M HewittCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Stephen M HewittCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Jochen K LennerzCenter for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School
David A MooreCRUK Lung Cancer Centre of Excellence, UCL and Cellular Pathology Department
Lajos PusztaiYale Cancer Center, Yale University
Lajos PusztaiYale School of Medicine, Yale University
Nasir RajpootUniversity of Warwick
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
David L RimmYale University School of Medicine
David L RimmYale University School of Medicine
Joel SaltzStony Brook University
Joel SaltzStony Brook University
Christos SotiriouInstitut Jules Bordet, Hopital Universitaire de Bruxelles (HUB), Universite Libre de Bruxelles (ULB)
Christos SotiriouInstitut Jules Bordet, Hopital Universitaire de Bruxelles (HUB), Universite Libre de Bruxelles (ULB)
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Albrecht Stenzinger
William F SymmansUniversity of Texas MD Anderson Cancer Center
Jeroen A W M van der LaakRadboud University Medical Center
Paul J van DiestUniversity Medical Center Utrecht
Paul J van DiestJohns Hopkins Oncology Center
Michael ViethInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg
Thomas WalterPSL University
Thomas WalterINSERM
Thomas WalterInstitut Curie, PSL University
Thomas WalterPSL University
Thomas WalterInstitut Curie, PSL University
Thomas WalterINSERM
Hannah Y WenMemorial Sloan Kettering Cancer Center
Wei YangFudan Medical University Shanghai Cancer Center
John M S BartlettUniversity of Edinburgh
  • 1 - 40

Datasets